Survival Outcomes of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Treated in the Chemoimmunotherapy Vs BTK Inhibitor (BTKi) Eras: A European Research Initiative on CLL (ERIC) StudyT C, David Oscier, Francesca Bacchiarri et al.|Blood|2024Cited by 0
Real-world treatment patterns and outcomes in patients with CLL and cardiovascular comorbidities: Interim analysis of the multicenter study conducted by eric.Thomas Chatzikonstantinou, Lydia Scarfò, Persefoni Talimtzi et al.|Blood|2025Cited by 0
Survival differences of patients with treatment-naive CLL between the chemoimmunotherapy and BTKi eras: An eric study.Thomas Chatzikonstantinou, Anna Puiggros, Persefoni Talimtzi et al.|Blood|2025Cited by 0